Inventor · disambiguated record
Neville Espi Sanjana
Also filed as: SANJANA NEVILLE · SANJANA NEVILLE E · SANJANA NEVILLE ESPI
13 granted patents·29 pending applications·1,748 citations·filing 2013–2025
92Inventor score
Files withBROAD INST INC26NEW YORK GENOME CENTER INC10MASSACHUSETTS INST TECHNOLOGY3CHILDRENS MEDICAL CT CORP2ZHANG FENG1
Top patents by PatentIndex Score
42 records- 0198US9822372B2CRISPR-Cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2016·Granted Nov 21, 2017·173 cites·8 claims
- 0298US8999641B2Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domainsBROAD INST INC·Filed 2014·Granted Apr 7, 2015·709 cites·28 claims
- 0398US8993233B2Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domainsBROAD INST INC·Filed 2013·Granted Mar 31, 2015·806 cites·43 claims
- 0496US11286478B2Cpf1 complexes with reduced indel activityBROAD INST INC·Filed 2017·Granted Mar 29, 2022·22 cites·28 claims
- 0594US10781444B2Functional genomics using CRISPR-Cas systems, compositions, methods, screens and applications thereofBROAD INST INC·Filed 2015·Granted Sep 22, 2020·31 cites·15 claims
- 0692US12344838B2CPF1 complexes with reduced indel activityBROAD INST INC·Filed 2022·Granted Jul 1, 2025·1 cites·32 claims
- 0788US11572543B2Targeting BCL11A enhancer functional regions for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2016·Granted Feb 7, 2023·4 cites·7 claims
- 0884US11685917B2Functional genomics using CRISPR-Cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereofBROAD INST INC·Filed 2017·Granted Jun 27, 2023·2 cites·37 claims
- 0982US2022135985A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2021·Application pending·0 cites
- 1081US12497610B2Functional genomics using CRISPR-CAS systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereofBROAD INST INC·Filed 2023·Granted Dec 16, 2025·0 cites·6 claims
- 1180US2020032278A1Crispr-cas component systems, methods and compositions for sequence manipulationMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 1280US2020080094A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2019·Application pending·0 cites
- 1380US2020032277A1Crispr-cas component systems, methods and compositions for sequence manipulationMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 1480US2020063147A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2019·Application pending·0 cites
- 1578US2024167018A1Functional genomics using crispr-cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereofBROAD INST INC·Filed 2023·Application pending·0 cites
- 1676US2019040399A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2018·Application pending·0 cites
- 1776US2019017058A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2018·Application pending·0 cites
- 1875US2018179547A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2018·Application pending·0 cites
- 1973US2025250577A1Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domainsBROAD INST INC·Filed 2025·Application pending·0 cites
- 2073US2014189896A1Crispr-cas component systems, methods and compositions for sequence manipulationZHANG FENG·Filed 2013·Application pending·0 cites
- 2171US2018327756A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2016·Application pending·0 cites
- 2271US2023235285A1Targeting bcl11a enhancer functional regions for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 2370US2019390204A1Inducible dna binding proteins and genome perturbation tools and applications thereofBROAD INST INC·Filed 2019·Application pending·0 cites
- 2470US2016115489A1Crispr-cas component systems, methods and compositions for sequence manipulationBROAD INST INC·Filed 2016·Application pending·0 cites
- 2569US2019203212A1Inducible dna binding proteins and genome perturbation tools and applications thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 2665US12454687B2Functional genomics using CRISPR-Cas systems, compositions, methods, knock out libraries and applications thereofBROAD INST INC·Filed 2019·Granted Oct 28, 2025·0 cites·13 claims
- 2763US2025195572A1Methods and compositions comprising fusion proteins for improved immunotherapiesNEW YORK GENOME CENTER INC·Filed 2023·Application pending·0 cites
- 2863US2017166903A1Inducible dna binding proteins and genome perturbation tools and applications thereofBROAD INST INC·Filed 2016·Application pending·0 cites
- 2962US12441995B2Functional genomics using CRISPR-Cas systems, compositions, methods, screens and applications thereofBROAD INST INC·Filed 2020·Granted Oct 14, 2025·0 cites·17 claims
- 3059US2015291965A1Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domainsBROAD INST INC·Filed 2015·Application pending·0 cites
- 3159US2024240208A1Compositions and methods for increasing efficiency of precise editing repairNEW YORK GENOME CENTER INC·Filed 2022·Application pending·0 cites
- 3258US2015291966A1Inducible dna binding proteins and genome perturbation tools and applications thereofBROAD INST INC·Filed 2015·Application pending·0 cites
- 3358US2014357530A1Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereofBROAD INST INC·Filed 2014·Application pending·0 cites
- 3458US2024043840A1Chemically modified crispr-cas13 guide rnasNEW YORK GENOME CENTER INC·Filed 2021·Application pending·0 cites
- 3557US2024307444A1Methods and compositions for improved immunotherapiesNEW YORK GENOME CENTER INC·Filed 2022·Application pending·0 cites
- 3655US2025262268A1Methods and Compositions for Inhibiting Viral InfectionNEW YORK GENOME CENTER INC·Filed 2021·Application pending·0 cites
- 3753US2023022311A1Methods and compositions involving crispr class 2, type vi guidesNEW YORK GENOME CENTER INC·Filed 2020·Application pending·0 cites
- 3852US2024124873A1Methods and compositions for combinatorial targeting of the cell transcriptomeNEW YORK GENOME CENTER INC·Filed 2022·Application pending·0 cites
- 3952US2022267759A1Methods and compositions for scalable pooled rna screens with single cell chromatin accessibility profilingNEW YORK GENOME CENTER INC·Filed 2020·Application pending·0 cites
- 4051US12460200B2Methods and compositions comprising CRISPR-Cpf1 and paired guide CRISPR RNAs for programmable genomic deletionsNEW YORK GENOME CENTER INC·Filed 2020·Granted Nov 4, 2025·0 cites·20 claims
- 4151US2021301269A1Recombinant crispr-cas9 nucleases with altered pam specificityNEW YORK GENOME CENTER INC·Filed 2021·Application pending·0 cites
- 4248US12116619B2CRISPR mediated in vivo modeling and genetic screening of tumor growth and metastasisBROAD INST INC·Filed 2017·Granted Oct 15, 2024·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →